Global Cord Blood Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG393421030
USD
1.00
-0.05 (-4.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'22
Dec'21
Sep'21
Jun'21
Mar'21
Dec'20
Sep'20
Net Sales
46.81
49.61
48.49
48.81
46.66
43.88
41.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
46.81
49.61
48.49
48.81
46.66
43.88
41.28
Raw Material Cost
6.61
7.40
7.14
7.41
7.09
6.77
6.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
17.06
17.73
15.68
16.37
15.85
17.05
13.99
Other Expenses
0.08
0.11
0.09
0.08
0.08
0.14
0.07
Total Expenditure (Excl Depreciation)
24.43
26.20
23.69
24.56
23.78
25.18
21.17
Operating Profit (PBDIT) excl Other Income
22.400000000000002
23.4
24.8
24.2
22.9
18.700000000000003
20.099999999999998
Other Income
1.87
1.38
1.32
1.56
1.73
1.42
1.64
Operating Profit (PBDIT)
26.12
26.65
28.04
27.65
26.49
21.98
23.53
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-2.20
0.09
-1.95
0.87
-0.73
0.91
0.82
Gross Profit (PBDT)
40.20
42.22
41.35
41.40
39.57
37.11
34.82
Depreciation
1.85
1.86
1.91
1.84
1.88
1.86
1.77
Profit Before Tax
22.06
24.89
24.18
26.68
23.88
21.03
22.58
Tax
5.24
3.69
4.37
5.15
3.77
3.20
3.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.49
20.99
19.44
21.13
19.71
17.59
19.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.49
20.99
19.44
21.13
19.71
17.59
19.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.33
0.21
0.37
0.40
0.40
0.24
0.27
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.82
21.20
19.81
21.52
20.11
17.83
19.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
769.23
749.16
718.31
698.97
668.48
650.43
608.09
Earnings per share (EPS)
0.14
0.17
0.16
0.17
0.16
0.14
0.16
Diluted Earnings per share
0.14
0.17
0.16
0.17
0.16
0.14
0.16
Operating Profit Margin (Excl OI)
47.82%
47.2%
51.15%
49.67%
49.03%
42.63%
48.72%
Gross Profit Margin
51.09%
53.91%
53.8%
58.43%
55.2%
52.16%
58.99%
PAT Margin
35.23%
42.3%
40.09%
43.28%
42.25%
40.09%
46.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2022 is -5.65% vs 2.27% in Dec 2021

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2022 is -20.75% vs 7.07% in Dec 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2022 is -4.35% vs -5.24% in Dec 2021

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2022 has improved from Dec 2021

Compare Quarterly Results Of Global Cord Blood Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
46.81
0
46.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
46.81
0
46.81
Raw Material Cost
6.61
0
6.61
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
17.06
0
17.06
Other Expenses
0.08
0.00
0.08
Total Expenditure (Excl Depreciation)
24.43
0
24.43
Operating Profit (PBDIT) excl Other Income
22.39
0.00
22.39
Other Income
1.87
0
1.87
Operating Profit (PBDIT)
26.12
0
26.12
Interest
0.00
0
0.00
Exceptional Items
-2.20
0
-2.20
Gross Profit (PBDT)
40.20
0
40.20
Depreciation
1.85
0
1.85
Profit Before Tax
22.06
0
22.06
Tax
5.24
0
5.24
Provisions and contingencies
0
0
0.00
Profit After Tax
16.49
0
16.49
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
16.49
0
16.49
Share in Profit of Associates
0
0
0.00
Minority Interest
0.33
0
0.33
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.82
0
16.82
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
769.23
0
769.23
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
47.82%
0%
0.00
47.82%
Gross Profit Margin
51.09%
0%
0.00
51.09%
PAT Margin
35.23%
0%
0.00
35.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 4.68 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is -5.65% vs 2.27% in Dec 2021

stock-summary

YoY Growth in quarter ended Mar 2022 is 0.21% vs 8.60% in Mar 2021

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.68 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is -20.75% vs 7.07% in Dec 2021

stock-summary

YoY Growth in quarter ended Mar 2022 is -16.42% vs 40.56% in Mar 2021

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.42 Million
in Mar 2022

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2022 is -4.35% vs -5.24% in Dec 2021

stock-summary

YoY Growth in quarter ended Mar 2022 is -2.42% vs 6.90% in Mar 2021

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.82%
in Mar 2022

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2022 has improved from Dec 2021

stock-summary

YoY Growth in quarter ended Mar 2022 has fallen from Mar 2021